Jump to content

Halopropane

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:22, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Halopropane
Clinical data
Trade namesTebron
ATC code
  • None
Identifiers
  • 3-Bromo-1,1,2,2-tetrafluoropropane
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC3H3BrF4
Molar mass194.955 g·mol−1
3D model (JSmol)
  • C(C(C(F)F)(F)F)Br
  • InChI=1S/C3H3BrF4/c4-1-3(7,8)2(5)6/h2H,1H2
  • Key:YVWGMAFXEJHFRO-UHFFFAOYSA-N

Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.[2][3][4]

See also

References

  1. ^ Nigel R. Webster; Helen F. Galley (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5.
  2. ^ Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974.
  3. ^ Sanford L. Klein (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
  4. ^ Earl J. Catcott; J. F. Smithcors (1973). Progress in canine practice. American Veterinary Publications.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Halopropane&oldid=963847839"